气管切开时机与有创通气COVID-19患者临床结局:系统评价与Meta分析
该系统评价与Meta分析检索Medline、Embase、Cochrane、Scopus及medRxiv、bioRxiv、Research Square(2019年12月1日至2021年8月24日),纳入14项研究、累计2371例接受气管切开的有创通气COVID-19患者;早期气管切开定义为有创机械通气(IMV)启动后14天及以内行气管切开,晚期为之后任何时间。汇总采用随机效应模型计算OR或均数差(MD)及95%CI。结果显示,早期气管切开与IMV时间缩短(2098例;MD -9.08天,95%CI -10.91至-7.26天,p<0.01)和ICU住院时间缩短(1224例;MD -9.41天,95%CI -12.36至-6.46天,p<0.01)相关;死亡率在两组间相当(2343例;OR 1.09,95%CI 0.79-1.51,p=0.59)。作者认为,这些发现可能对疫情期间提高ICU可用性有重要意义。
要点
- 早期气管切开定义为IMV启动后14天及以内,晚期为之后任何时间。
- 早期气管切开与IMV时间缩短相关:2098例,MD -9.08天,95%CI -10.91至-7.26天,p<0.01。
- 早期气管切开与ICU住院时间缩短相关:1224例,MD -9.41天,95%CI -12.36至-6.46天,p<0.01。
- 死亡率两组相当:2343例,OR 1.09,95%CI 0.79-1.51,p=0.59。
- 作者认为,这些发现可能对疫情期间提高ICU可用性有重要意义。
适用人群与场景
- 接受有创机械通气(IMV)并接受气管切开的COVID-19患者,纳入14项研究、累计2371例气管切开患者。
诊断标准与关键阈值
- 早期气管切开:IMV启动后14天及以内行气管切开;晚期气管切开:14天之后任何时间。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,检索Medline、Embase、Cochrane、Scopus及medRxiv、bioRxiv、Research Square,时间范围2019年12月1日至2021年8月24日;纳入14项研究、累计2371例气管切开COVID-19患者;采用随机效应模型汇总OR或MD及95%CI。
- 主要结局IMV时间:早期气管切开组较晚期组缩短,2098例,MD -9.08天,95%CI -10.91至-7.26天,p<0.01。
- 主要结局ICU住院时间:早期气管切开组较晚期组缩短,1224例,MD -9.41天,95%CI -12.36至-6.46天,p<0.01。
- 主要结局总死亡率:两组相当,2343例,OR 1.09,95%CI 0.79-1.51,p=0.59。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析;方案注册于INPLASY(INPLASY202180088)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与晚期气管切开相比,COVID-19患者早期气管切开与更短的IMV时间和ICU住院时间相关,且不改变死亡率;这些发现可能对疫情期间提高ICU可用性有重要意义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The association of tracheostomy timing and clinical outcomes in ventilated COVID-19 patients remains controversial. We performed a meta-analysis to evaluate the impact of early tracheostomy compared to late tracheostomy on COVID-19 patients' outcomes.
METHODS: We searched Medline, Embase, Cochrane, and Scopus database, along with medRxiv, bioRxiv, and Research Square, from December 1, 2019, to August 24, 2021. Early tracheostomy was defined as a tracheostomy conducted 14 days or less after initiation of invasive mechanical ventilation (IMV). Late tracheostomy was any time thereafter. Duration of IMV, duration of ICU stay, and overall mortality were the primary outcomes of the meta-analysis. Pooled odds ratios (OR) or the mean differences (MD) with 95%CIs were calculated using a random-effects model.
RESULTS: Fourteen studies with a cumulative 2371 tracheostomized COVID-19 patients were included in this review. Early tracheostomy was associated with significant reductions in duration of IMV (2098 patients; MD - 9.08 days, 95% CI - 10.91 to - 7.26 days, p < 0.01) and duration of ICU stay (1224 patients; MD - 9.41 days, 95% CI - 12.36 to - 6.46 days, p < 0.01). Mortality was reported for 2343 patients and was comparable between groups (OR 1.09, 95% CI 0.79-1.51, p = 0.59).
CONCLUSIONS: The results of this meta-analysis suggest that, compared with late tracheostomy, early tracheostomy in COVID-19 patients was associated with shorter duration of IMV and ICU stay without modifying the mortality rate. These findings may have important implications to improve ICU availability during the COVID-19 pandemic. Trial registration The protocol was registered at INPLASY (INPLASY202180088).
参考来源
- Ji Y, Fang Y, Cheng B, et al. Tracheostomy timing and clinical outcomes in ventilated COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2022. PMID: 35135597. doi:10.1186/s13054-022-03904-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。